A clinical trial for a possible CCP virus vaccine began in the United Kingdom on Thursday, researchers said.
The vaccine candidate was developed by the University of Oxford. The trial is being run by the Jenner Institute and Oxford Vaccine Group.
A computer image created by Nexu Science Communication together with Trinity College in Dublin, shows a model structurally representative of a betacoronavirus which is the type of virus linked to COVID-19. NEXU Science Communication/via Reuters
Zachary Stieber
Senior Reporter
|Updated:
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
Author’s Selected Articles
